跳至主要内容
临床试验/EUCTR2021-000701-24-NL
EUCTR2021-000701-24-NL进行中(未招募)1 期

Switching of COVID-19 Vaccines: a solution for the problems? - SWITCH

Erasmus MC0 个研究点目标入组 600 人开始时间: 2021年3月22日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Erasmus MC
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All HCW who work in the health care facility with at least one confirmed SARS CoV-2 infected patient receiving care and who have symptoms associated with SARS CoV-2.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 600
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • 1.HCW younger than 18
  • 2.HCW that are pregnant or have a wish to become pregnant within 6 months
  • 3.All regular contra-indications of the vaccines will be applied

研究者

发起方
Erasmus MC

相似试验

Switching of COVID-19 Vaccines: a solution for the... | 临床试验